Back in 2015 a study titled “Lacerations and Embedded Needles Caused by Epinephrine Autoinjector Use in Children” was released in the Annals of Emergency Medicine, an International Journal. The study looked at complications of epinephrine autoinjector use in children and discuss features of these devices, and their instructions for use, and how these may contribute to injuries.
It was concluded that the Epinephrine autoinjectors are lifesaving devices in the management of anaphylaxis. However, some have caused lacerations and other injuries in children. It was suggested that minimizing needle injection time, improving device design, and providing instructions to immobilise the leg before use may decrease the risk of these injuries.
In 2017, the Therapeutic Goods Administration (TGA) provided permission to make the changes in Australia, and so we saw the reduced injection time change from 10 to 3 seconds.